ACS Combinatorial Science
RESEARCH ARTICLE
T. B.; Faust, K. A.; Greenlee, W. J.; Kivlighn, S. D.; Lotti, V. J.; O'Malley,
S. S.; Schorn., T. W.; Siegl, P. K.; Tran, J.; Zingaro, G. J. The SAR of
6-(N-Alkyl-N-acyl)-2-propyl-3-[(20-tetrazol-5-yl)biphen-4-yl)methyl]-
quinazolinones as Balanced Affinity Antagonists of the Human AT1 and
AT2 Receptors. Bioorg. Med. Chem. Lett. 1995, 5, 1359–1364. (c) Johne,
S. Quinazoline Derivatives in Pharmaceutical Research. Pharmazie
1981, 36, 583–596.
(2) (a) Horton, D. A.; Bourne, G. T.; Smythe, M. L. The Combi-
natorial Synthesis of Bicyclic Privileged Structures or Privileged Sub-
structures. Chem. Rev. 2003, 103, 893–930. (b) Liu, J. F.; Wilson, C. J.;
Ye, P.; Sprague, K.; Sargent, K.; Si, Y.; Beletsky, G.; Yohannes, D.; Ng,
S. C. Privileged Structure-Based Quinazolinone Natural Product-templated
Libraries: Identification of Novel Tubulin Polymerization Inhibitors. Bioorg.
Med. Chem. Lett. 2006, 16, 686–690.
(3) (a)Evans, B. E.; Rittle, K. E.;Bock, M. G.;DiPardo, R. M.;Freidinger,
R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang,
R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kunkel, K. A.;
Springer, J. P.; Hirshfieldt, J. Methods for Drug Discovery: Development of
Potent, Selective, Orally Effective Cholecystokinin Antagonists. J. Med. Chem.
1988, 31, 2235–2246. (b) Duarte, C. D.; Barreiro, E. J.; Fraga, C. A. M.
Privileged Structures: A Useful Concept for the Rational Design of New Lead
Drug Candidates. Mini.-Rev. Med. Chem. 2007, 7, 1108–1119.
(4) Alagarsamy, V.; Raja S., V.; Dhanabal, K. Synthesis and Pharmaco-
logical Evaluation of Some 3-Phenyl-2-substituted-3H-quinazolin-4-one as
Analgesic, Anti-inflammatory Agents. Bioorg. Med. Chem. 2007, 15, 235–241.
(5) Alagarsamy, V.; Pathak, U. S. Synthesis and Antihypertensive
Activity of Novel 3-Benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quina-
zolin-9-ones. Bioorg. Med. Chem. 2007, 15, 3457–3462.
Jagadeeswaran, M. Synthesis and Anticonvulsant Activity of New 2-
(Substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-
1,2,3,4-tetrahydroquinazolin-4(3H)-one Derivatives. Asian J. Chem.
2006, 18, 2611–2617. (c) Colotta, V.; Catarzi, D.; Varano, F.; Cecchi,
L.; Filacchioni, G.; Galli, A.; Costagli, C. Synthesis and Biological
Evaluation of a Series of Quinazoline-2-carboxylic Acids and Quinazo-
line-2,4-diones as Glycine-NMDA Antagonists: a Pharmacophore Mod-
el Based Approach. Arch. Pharm. 1997, 330, 129–134. (d) Fulop, F.;
Simeonov, M.; Pihlaja, K. Formation of 1,2-Dihydroquinazolin-4(3H)-
ones. Reinvestigation of a Recently Reported 1,3,4-Benzotriazepine
Synthesis. Tetrahedron 1992, 48, 531–538. (e) Reddy, P. S. N.; Reddy,
P. Reaction of 2-Aminobenzoylhydrazines with Ketones: Synthesis of
3-Aminoquinazolin-4(3H)-ones and 1,3,4-Benzotriazepin-5-one Deri-
vatives. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1988, 27B,
135–139. (f) Khan, M. T. H.; Khan, R.; Wuxiuer, Y.; Arfan, M.; Ahmed,
M.; Sylte, I. Identification of Novel Quinazolin-4(3H)-ones as Inhibitors
of Thermolysin, the Prototype of the M4 Family of Proteinases. Bioorg.
Med. Chem. 2010, 18, 4317–4327.
(15) (a) Cho, C.-H.; Neuenswander, B.; Lushington, G. H.; Larock,
R. C. Solution-Phase Parallel Synthesis of a Multi-substituted Benzo-
[b]thiophene Library. J. Comb. Chem. 2009, 11, 900–906. (b) Zeng, L.-
H.; Cai, C. Iodine Catalyzed One-Pot Multicomponent Synthesis of a
Library of Compounds Containing Tetrazolo[1,5-a]pyrimidine Core.
J. Comb. Chem. 2010, 12, 35–40. (c) Das, B.; Balasubramanyam, P.;
Krishnaiah, M.; Veeranjaneyulu, B.; Reddy, G. C. Iodine-Catalyzed
Efficient Hydrophosphonylation of N-Tosyl Aldimines. J. Org. Chem.
2009, 74, 4393–4395. (d) Wang, G.-W.; Gao, J. Selective Formation of
Spiro Dihydrofurans and Cyclopropanes Through Unexpected Reaction
of Aldehydes with 1,3-Dicarbonyl Compounds. Org. Lett. 2009, 11,
2385–2388. (e) Mal, D.; De, S. R. Total Synthesis of Euplectin, a Natural
Product with a Chromone Fused Indenone. Org. Lett. 2009, 11, 4398–
4401. (f) Parvatkar, P. T.; Parameswaran, P. S.; Tilve, S. G. An Expedi-
tious I2-Catalyzed Entry into 6H-Indolo[2,3-b]quinoline System of
Cryptotackieine. J. Org. Chem. 2009, 74, 8369–8372.
(6) Murugan, V.; Kulkarni, M.; Anand, R. M.; Kumar, E. P.;
Suresh, B.; Reddy, V. M. Synthesis of 2-[{Bis-(2-chloroethyl)amino}-
methyl]-6,8-dinitro-1-(4-substituted phenyl)-1H-quinazolin-4-one Deriva-
tives as Possible Antineoplastic Agents. Asian J. Chem. 2006, 18, 900–906.
(7) Godfrey, A. A. A. A Preparation of Quinazolin-4-ones via Cycliza-
tion of N-(cyanophenyl)acetamide Derivatives. PCT Int. Appl. WO
2005012260 A2 10 Feb 2005; Chem. Abstr. 2005, 142, 198095.
(8) Selvam, P.; Girija, K.; Nagarajan, G.; De Clerco, E. Synthesis,
Antibacterial and Anti-HIV Activities of 3-(5-Amino-6-(2-3-dichloro-
phenyl)-(1,2,4) triazin-3-yl)-6,8-dibromo-2-substituted-3H-quinozolin-
4-one. Indian J. Pharm. Sci. 2005, 67, 484–487.
(16) Wang, X. S.; Yang, K.; Zhou, J.; Tu, S. J. Facile Method for the
Combinatorial Synthesis of 2,2-Disubstituted Quinazolin-4(1H)-one
Derivatives Catalyzed by Iodine in Ionic Liquids. J. Comb. Chem. 2010,
12, 417–421.
(17) (a) Wang, X. S.; Zhang, M. M.; Jiang, H.; Tu, S. J. An Improved
and Clean Procedure for the Synthesis of One-Donor Poly-Acceptors
Systems Containing 2,6-Dicyanoamine Moiety in Aqueous Media
Catalyzed by TEBAC in the Presence and Absence of K2CO3. Tetra-
hedron 2007, 63, 5265–5273. (b) Wang, X. S.; Zhang, M. M.; Jiang, H.;
Tu, S. J. Three-Component Green Synthesis of N-arylquinoline Deri-
vatives in Ionic Liquid [Bmimþ][BF4-]: Reactions of Arylaldehyde,
3-Arylamino-5,5-dimethylcyclohex-2-enone, and Active Methylene Com-
pounds. Tetrahedron 2007, 63, 4439–4449. (c) Wang, X. S.; Wu, J. R.; Li,
Q.; Yao, C. S.; Tu, S. J. A Novel and Green Method for the Synthesis of
Indeno[2,1-c]pyridine Derivatives in Ionic Liquid Catalyzed by Malono-
nitrile. Synlett 2008, 1185–1188. (d) Wang, X. S.; Zhang, M. M.; Li, Q.;
Yao, C. S.; Tu, S. J. An Unexpected Triethylbenzylammonium Chloride
Catalyzed Ring Opening of 2-Pyrones in the Synthesis of 1-Arylbenzo-
[f]quinoline-2-carboxamide Derivatives in Aqueous Media. Synlett 2007,
3141–3144. (e) Wang, X. S.; Wu, J. R.; Zhou, J;Tu, S. J. Green Method for
the Synthesis of Highly Substituted Cyclohexa-1,3-diene, Polyhydroindene,
Polyhydronaphthalene, Isochromene, Isothiochromene, and Isoquinoline
Derivatives in Ionic Liquids. J. Comb. Chem. 2009, 11, 1011–1022.
(18) (a) Ji, S. J.; Wang, S. Y.; Zhang, Y.; Loh, T. P. Facile Synthesis of
Bis(indolyl)methanes Using Catalytic Amount of Iodine at Room
Temperature under Solvent-Free Conditions. Tetrahedron 2004, 60,
2051–2055. (b) Wang, X. S.; Li, Q.; Wu, J. R.; Tu, S. J. Efficient Method
for the Synthesis of Pyranoquinoline, Thiopyranoquinoline, Thienoqui-
noline, and Naphtho[2,7]naphthyridine Derivatives Catalyzed by
Iodine. J. Comb. Chem. 2009, 11, 433–437. (c) Wang, X. S.; Li, Q.; Yao,
C. S.; Tu, S. J. An Efficient Method for the Synthesis of Benzo[f]quinoline
and Benzo[a]phenanthridine Derivatives Catalyzed by Iodine by a Three-
Component Reaction of Arenecarbaldehyde, Naphthalen-2-amine, and
Cyclic Ketone. Eur. J. Org. Chem. 2008, 3513–3518.
(9) Alanine, A.; Gobbi, L. C.; Kolczewski, S.; Luebbers, T.; Peters,
J.-U.; Steward, L. Preparation of 8-Alkoxy or Cycloalkoxy-4-methyl-3,4-
dihydro-quinazolin-2-ylamines for Treating 5-HT5A Receptor Related
Diseases. U.S. Patent US 2006293350 A1 28 Dec 2006; Chem. Abstr.
2006, 146, 100721.
(10) Chaturvedula, P. V.; Chen, L. Civiello, R.; Degnan, A. P.;
Dubowchik, G. M.; Han, X.; Jiang, X. J.; Macor, J. E.; Poindexter, G. S.;
Tora, G. O.; Luo, G. Preparation of Piperidine-1-carboxamide Derivatives
and Spirocycles Thereof as Antagonists of Calcitonin Gene-related
Peptide Receptors. U.S. Patent US 2007149503 A1 28 Jun 2007; Chem.
Abstr. 2007, 147, 118256.
(11) Letourneau, J.; Riviello, C.; Ho, K.-K.; Chan, J.-H.; Ohlmeyer,
M.; Jokiel, P.; Neagu, I.; Morphy, J. R.; Napier, S. E. Preparation of 2-(4-
Oxo-4H-quinazolin-3-yl)acetamides as Vasopressin V3 Receptor An-
tagonists. PCT Int. Appl. WO 2006095014 A1 14 Sep 2006; Chem.
Abstr. 2006, 145, 315012.
(12) DeRuiter, J.; Brubaker, A. N.; Millen, J.; Riley, T. N. Design and
Synthesis of 2-(Arylamino)-4(3H)-quinazolinones as Novel Inhibitors
of Rat Lens Aldose Reductase. J. Med. Chem. 1986, 29, 627–629.
(13) (a) Hess, H. J.; Cronin, T. H.; Scriabine, A. Antihypertensive
2-Amino-4(3H)-quinazolinones. J. Med. Chem. 1968, 11, 130–136. (b)
Hussain, M. A.; Chiu, A. T.; Price, W. A.; Timmermans, P. B.; Shefter, E.
Antihypertensive Activity of 2[(2-Hydroxyphenyl)amino]-4(3H)-qui-
nazolinone. Pharm. Res. 1988, 5, 242–244.
(14) (a) Gudasi, K. B.; Vadavi, R. S.; Shenoy, R. V.; Patil, S. A.;
Nethaji, M. Crystal Structure of 2-Thiophene-2-yl-3(thiophene-2-car-
boxylideneamino)-1,2-dihydroquinazolin-4(3H)-one and the Synthesis,
Spectral and Thermal Studies of its Transition Metal(II) Complexes.
Trans. Met. Chem. 2006, 31, 374–381. (b) Gopal, N.; Saravanan, V. S.;
199
dx.doi.org/10.1021/co1000713 |ACS Comb. Sci. 2011, 13, 196–199